NOVOCURE LTD's ticker is and the CUSIP is 67011XAB9. A total of 33 filers reported holding NOVOCURE LTD in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STEELHEAD PARTNERS LLC | 60,500,000 | $55,131,000 | 3.79% |
| Ayrton Capital LLC | 1,500,000 | $1,367,000 | 1.78% |
| DeepCurrents Investment Group LLC | 58,391,000 | $53,156,000 | 1.66% |
| ABSOLUTE INVESTMENT ADVISERS, LLC | 6,000,000 | $5,460,000 | 1.22% |
| Context Capital Management, LLC | 12,900 | $11,757,000 | 0.76% |
| WOLVERINE ASSET MANAGEMENT LLC | 74,842,000 | $68,091,000 | 0.66% |
| Verition Fund Management LLC | 41,383,000 | $37,762,000 | 0.45% |
| CSS LLC/IL | 13,560,000 | $12,426,000 | 0.45% |
| Aequim Alternative Investments LP | 18,000,000 | $16,425,000 | 0.43% |
| Empyrean Capital Partners, LP | 10,000,000 | $9,125,000 | 0.20% |